Medica SurB de CV's revenue for the
three
months ended in Dec. 2025 was $67.9 Mil.
Its revenue for the trailing twelve months (TTM) ended in Dec. 2025 was $253.9 Mil.
Medica SurB de CV's Revenue per Share for the
three
months ended in Dec. 2025 was $0.64.
Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $2.35.
Good Sign:
Medica Sur SAB de CV has shown predictable revenue and earnings growth.
During the past 12 months, the average Revenue per Share Growth Rate of Medica SurB de CV was 8.00% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 7.30% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 11.10% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 8.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 13 years, Medica SurB de CV's highest 3-Year average Revenue per Share Growth Rate was 17.10% per year. The lowest was -2.90% per year. And the median was 7.30% per year.
Medica SurB de CV (OTCPK:MSURF) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Medica SurB de CV Revenue Related Terms
Medica SurB de CV Revenue Historical Data
* Premium members only.
The historical data trend for Medica SurB de CV's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Medica SurB de CV's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medica SurB de CV Revenue vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medica SurB de CV's Revenue distribution charts can be found below:
* The bar in red indicates where Medica SurB de CV's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $253.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medica SurB de CV (MSURF) has a Revenue of $253.9 Mil as of Dec. 2025. Revenue is the total amount a company generates as sales through its operations. View historical data on Medica SurB de CV and its competitors.
Is Medica SurB de CV's Revenue too high?
Medica SurB de CV's current Revenue is $253.9 Mil. Overall, Medica SurB de CV has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Medica SurB de CV's Revenue compare to HCA and THC?
Medica SurB de CV's Revenue of $253.9 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Healthcare Providers & Services company?
A good Revenue depends on the Healthcare Providers & Services industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Medica SurB de CV and its competitors. Medica SurB de CV's current Revenue is $253.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medica SurB de CV stock overvalued right now?
Medica SurB de CV (MSURF) has a current Revenue of $253.9 Mil. The stock's GF Value™ is $0.53, compared to a current price of $0.67 — trading 27% above its estimated fair value. The current Revenue is $253.9 Mil. Medica SurB de CV's overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Medica SurB de CV (MSURF), the current Revenue is $253.9 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medica SurB de CV (MSURF) Overvalued in 2026?
Based on GuruFocus' analysis, Medica SurB de CV stock appears to be overvalued.
The current stock price of $0.67 is trading 27% above its estimated GF Value™ of $0.53.
Key valuation signals for MSURF:
Revenue: $253.9 Mil
GF Value™: $0.53 vs. price of $0.67 (27% above fair value)
No single metric tells the full story. See the MSURF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medica Sur SAB de CV is a medical care company specializes in emergency scenarios. The company offers emergency ambulance transportation, air transportation and paramedic assistance.
81GF Score
Get the complete analysis for MSURF
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MSURF has been successfully added to your 
